Business

Business

Pipeline

Pipeline Potential Indication In-house

/Partnership

2018 2019 2020
ADC Breast Cancer

In-house

Optimization (Linker stability, in-vitro efficacy, Synthesis)

In Vivo Efficacy / PK

GLP Tox

Undisclosed Partnership PoC Optimization In Vivo Efficacy

/Toxicity

Long-acting bio pharmaceuticals Undisclosed In-house

PoC Optimization In Vivo Efficacy

/Toxicity

Micelle-CoQ10 Osteoarthritis Partnership Pre-clinical for IND

IND /

Human study

Health food / Joint protection In-house

Pre-clinical for filing

Human study

*Individual certification

Sjogren’s syndrome In-house

PoC (depending on PoC)

 
Micelle-Lutein

Health food / eye

In-house

PoC (depending on PoC)

 
위로이동